RYC(003010) 同花顺财报·2025-04-24 12:20Financial Performance - The company reported a basic earnings per share of 0.6500 yuan for 2024, a 96.97% increase compared to 0.3300 yuan in 2023 [1] - The total revenue for 2024 was 17.66 billion yuan, reflecting a 29.28% increase from 13.66 billion yuan in 2023 [1] - The net profit for 2024 reached 1.06 billion yuan, up 96.3% from 0.54 billion yuan in 2023 [1] - The return on equity (ROE) improved to 9.62% in 2024, a significant increase of 92.02% from 5.01% in 2023 [1] - The net asset per share decreased by 24.97% to 6.73 yuan in 2024 from 8.97 yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 58.01 million shares, accounting for 47.98% of the circulating shares, with an increase of 6.2039 million shares compared to the previous period [1] - Notable shareholders include Langzi Co., Ltd. holding 1,637.03 million shares (13.54%), and Tianjin Yayi Biotechnology holding 1,344.00 million shares (11.11%) [2] - New entrants among the top shareholders include Xingquan Commercial Model Mixed Fund A with 500.74 million shares (4.14%) and Xingquan New Vision Fund with 259.78 million shares (2.15%) [2] Dividend Distribution - The company announced a dividend distribution plan of 10 shares for every 4 shares held, along with a cash dividend of 5 yuan (including tax) [4]